These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 32438969)
21. Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis. Saito S; Ojima H; Ichikawa H; Hirohashi S; Kondo T Cancer Sci; 2008 Dec; 99(12):2402-9. PubMed ID: 19038010 [TBL] [Abstract][Full Text] [Related]
22. Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway. Zhang C; Zhang J; Wang J; Yan Y; Zhang C J Cell Mol Med; 2020 Dec; 24(23):13804-13812. PubMed ID: 33090723 [TBL] [Abstract][Full Text] [Related]
23. Identification of Key Hydroxymethylated Genes and Transcription Factors Associated with Alpha-Fetoprotein-Negative Hepatocellular Carcinoma. Zhang L; Wang K; Deng Q; Li W; Zhang X; Liu X DNA Cell Biol; 2019 Nov; 38(11):1346-1356. PubMed ID: 31618054 [TBL] [Abstract][Full Text] [Related]
24. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC). Chen GG; Ho RL; Wong J; Lee KF; Lai PB Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605 [TBL] [Abstract][Full Text] [Related]
25. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter. Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409 [TBL] [Abstract][Full Text] [Related]
26. Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma. Görög D; Regöly-Mérei J; Paku S; Kopper L; Nagy P World J Gastroenterol; 2005 Aug; 11(32):5015-8. PubMed ID: 16124056 [TBL] [Abstract][Full Text] [Related]
27. Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm. Zhang C; Chen X; Liu H; Li H; Jiang W; Hou W; McNutt MA; Lu F; Li G Int J Cancer; 2015 Oct; 137(8):1818-29. PubMed ID: 25846475 [TBL] [Abstract][Full Text] [Related]
28. ING1 represses transcription by direct DNA binding and through effects on p53. Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900 [TBL] [Abstract][Full Text] [Related]
29. A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells. Cao G; Kuriyama S; Tsujinoue H; Chen Q; Mitoro A; Qi Z Int J Cancer; 2000 Jul; 87(2):247-52. PubMed ID: 10861483 [TBL] [Abstract][Full Text] [Related]
30. Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation. Zhang C; Li H; Jiang W; Zhang X; Li G Oncotarget; 2016 Dec; 7(50):83755-83766. PubMed ID: 27835879 [TBL] [Abstract][Full Text] [Related]
31. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma. Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685 [TBL] [Abstract][Full Text] [Related]
32. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374 [TBL] [Abstract][Full Text] [Related]
33. Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer. Peterson ML; Ma C; Spear BT Semin Cancer Biol; 2011 Feb; 21(1):21-7. PubMed ID: 21216289 [TBL] [Abstract][Full Text] [Related]
34. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells. Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059 [TBL] [Abstract][Full Text] [Related]
35. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. Fatima S; Luk JM; Poon RT; Lee NP Expert Rev Mol Diagn; 2014 Jun; 14(5):535-48. PubMed ID: 24809435 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of vitamin K1 on AFP and DCP levels in patients with unresectable HCC and in HCC cell lines. Carr BI; Wang Z; Wang M; Wei G Dig Dis Sci; 2011 Jun; 56(6):1876-83. PubMed ID: 21188521 [TBL] [Abstract][Full Text] [Related]
37. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma. Pin RH; Reinblatt M; Fong Y Ann Surg; 2004 Oct; 240(4):659-65; discussion 665-6. PubMed ID: 15383793 [TBL] [Abstract][Full Text] [Related]
38. An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma. Takikawa H; Mafune K; Hamada H; Nettelbeck DM; Müller R; Makuuchi M; Kaminishi M Int J Oncol; 2003 May; 22(5):1051-6. PubMed ID: 12684671 [TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological significance of ezrin and SIX1 protein expression in alpha fetoprotein-negative hepatocellular carcinoma]. Kong J; Zhou X; Han L; Quan C; Cui X; Lin Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):236-9. PubMed ID: 26927385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]